Skip To Main Content
Ruth Link-Gelles on Muck Rack

Ruth Link-Gelles

As seen in: Center for Disease Control and Prevention, Emerging Infectious Diseases Journal, Nature, JAMA (The Journal of the American Medical Association), JAMA Network, JAMA: Journal of the American Medical Association, Medscape, The New England Journal of Medicine, The Lancet, CDC Featured Podcasts
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ruth

Contact Ruth, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Estimated Effectiveness of 2024-2025 COVID-19 Vaccines in Adults

|
By Ryan Wiegand, Amanda Payne, Josephine Mak, Sean Chickery, Sarah Reese, Nicola P. Klein, Shaun Grannis, Toan C Ong, Elizabeth Rowley, Malini DeSilva, Kristin Dascomb, Stephanie A. Irving, Ousseny Zerbo, John Hansen, Lawrence Block, Karen B. Jacobson, Colin Rogerson, Thomas Duszynski, William F Fadel, Michelle Barron, David Mayer, Catia Chávez, Duck-Hye Yang, Charlene E. McEvoy, Omobosola Akinsete, Tamara Sheffield, Daniel Bride, Julie Arndorfer, Allison L. Naleway, Karthik Natarajan, Morgan Najdowski, Allison Avrich Ciesla, Amber Kautz, Jennifer DeCuir, Ruth Link-Gelles, Joshua Van Otterloo, Sarah Ball
| JAMA Network Verified
Estimated Effectiveness of 2024-2025 COVID-19 Vaccines in Adults Key Points Question What was the effectiveness of 2024-2025 COVID-19 vaccines against medically attended COVID-19 among adults 18 years and older in the US?
Open in Who Shared Issue with article?

Interim Estimated Effectiveness of 2025-2026 COVID-19 Vaccines in Adults Using a Test-Negative Design

|
By Ryan Wiegand, Sean Chickery, Duck-Hye Yang, Malini DeSilva, Kristin Dascomb, Stephanie A. Irving, Karthik Natarajan, Nicola P. Klein, Shaun Grannis, Toan C Ong, Elizabeth Rowley, Adam Yates, Yan Zhuang Verified, Charlene E. McEvoy, Omobosola Akinsete, Allison L. Naleway, Padma Koppolu, Ousseny Zerbo, John Hansen, Karen B. Jacobson, Lawrence Block, Thomas Duszynski, Colin Rogerson, Michelle Barron, Catia Chávez, Josephine Mak, Allison Avrich Ciesla, Monica Godfrey, Morgan Najdowski, Ruth Link-Gelles, Jennifer DeCuir, Amanda Payne, Inih J. Essien, Amber Kautz, Sarah Ball
| JAMA Network Verified
Interim Estimated Effectiveness of 2025-2026 COVID-19 Vaccines in Adults Using a Test-Negative Design Supplement 1. eTable 1. International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10) used to define COVID-19-like illness eTable 2. International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10) used to define underlying medical condition and immunocompromise status Supplement 2. Table 1.
Open in Who Shared Issue with article?

Estimated 2023-2024 COVID-19 Vaccine Effectiveness in Adults

|
By Ruth Link-Gelles
| JAMA (The Journal of the American Medical Association) Verified
Estimated 2023-2024 COVID-19 Vaccine Effectiveness in Adults Supplement 1. eTable 1. Number of Emergency Departments, Urgent Cares, and Hospitals, by Participating VISION Study Site eTable 2. International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10) Used to Define COVID-19-Like Illness eTable 3. International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10) Used to Define eTable 4.
Open in Who Shared Issue with article?
See all 25 licensed articles (53 Total)